{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:48:31Z","timestamp":1791413311007,"version":"4.3.3"},"reference-count":22,"publisher":"Bentham Science Publishers Ltd.","issue":"3","funder":[{"DOI":"10.13039\/501100004410","name":"Scientific and Technological Research Council of Turkey","doi-asserted-by":"publisher","award":["123S150"],"award-info":[{"award-number":["123S150"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CRP"],"published-print":{"date-parts":[[2024,9]]},"abstract":"<jats:sec>\n<jats:title>Introduction:<\/jats:title>\n<jats:p>The most important toxicity of transarterial radioembolization therapy\napplied in liver malignancies is radiation pneumonitis and fibrosis due to hepatopulmonary\nshunt of Yttrium-90 (90Y) microspheres. Currently, Technetium-99m macroaggregated albumin\n(99mTc-MAA) scintigraphic images are used to estimate lung shunt fraction (LSF) before treatment.\nThe aim of this study was to create a phantom to calculate exact LFS rates according to\n99mTc activities in the phantom and to compare these rates with LSF values calculated from\nscintigraphic images.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Materials and Methods:<\/jats:title>\n<jats:p>A 3D-printed lung and liver phantom containing two liver tumors was\ndeveloped from Polylactic Acid (PLA) material, which is similar to the normal-sized human\nbody in terms of texture and density. Actual %LSFs were calculated by filling phantoms and\ntumors with 99mTc radionuclide. After the phantoms were placed in the water tank made of plexiglass\nmaterial, planar, SPECT, and SPECT\/CT images were obtained. The actual LSF ratio\ncalculated from the activity amounts filled into the phantom was used for the verification of the\nquantification of scintigraphic images and the results obtained by the Simplicity90YTM method.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>In our experimental model, LSFs calculated from 99mTc activities filled into the lungs,\nnormal liver, small tumor, and large tumor were found to be 0%, 6.2%, 10.8%, and 16.9%. According\nto these actual LSF values, LSF values were calculated from planar, SPECT\/CT (without\nattenuation correction), and SPECT\/CT (with both attenuation and scatter correction) scintigraphic\nimages of the phantom. In each scintigraphy, doses were calculated for lung, small tumor,\nlarge tumor, normal liver, and Simplicity90YTM. The doses calculated from planar and\nSPECT\/CT (NoAC+NoSC) images were found to be higher than the actual doses. The doses\ncalculated from SPECT\/CT (with AC+with SC) images and Simplicity90YTM were found to be\ncloser to the real dose values.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>LSF is critical in dosimetry calculations of 90Y microsphere therapy. The newly\nintroduced hepatopulmonary shunt phantom in this study is suitable for LSF verification for all\nmodels\/brands of SPECT and SPECT\/CT devices.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0118744710284130240108053733","type":"journal-article","created":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T17:02:55Z","timestamp":1706547775000},"page":"276-284","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Hepatopulmonary Shunt Ratio Verification Model for Transarterial\nRadioembolization"],"prefix":"10.2174","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0262-4020","authenticated-orcid":true,"given":"Nami","family":"Yeyin","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Fatih\/Istanbul,\nTurkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5110-1184","authenticated-orcid":true,"given":"Fahrettin Fatih","family":"Kesmezacar","sequence":"additional","affiliation":[{"name":"Vocational School of Health Service, Istanbul University-Cerrahpasa, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0929-0441","authenticated-orcid":true,"given":"Duygu","family":"Tun\u00e7man","sequence":"additional","affiliation":[{"name":"Vocational School of Health Service, Istanbul University-Cerrahpasa, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0342-5915","authenticated-orcid":true,"given":"\u00d6zge","family":"Demir","sequence":"additional","affiliation":[{"name":"Department of\nChemical Engineering, Engineering Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1868-3957","authenticated-orcid":true,"given":"Lebriz","family":"Uslu-Be\u015fli","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Fatih\/Istanbul,\nTurkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osman","family":"G\u00fcnay","sequence":"additional","affiliation":[{"name":"Department of\nBiomedical Engineering, Faculty of Electrical and Electronics Engineering, Y\u0131ld\u0131z Technical University, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9813-1628","authenticated-orcid":true,"given":"Mustafa","family":"Demir","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Fatih\/Istanbul,\nTurkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3390\/jcm8010055","volume":"8","author":"Saini A.","year":"2019","unstructured":"Saini A.; Wallace A.; Alzubaidi S.; Knuttinen M.G.; Naidu S.; Sheth R.; Albadawi H.; Oklu R.; History and evolution of Yttrium-90 radioembolization for hepatocellular carcinoma. J Clin Med  2019,8(1),55","journal-title":"J Clin Med"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s00259-015-3157-8","volume":"43","author":"Garin E.","year":"2016","unstructured":"Garin E.; Rolland Y.; Laffont S.; Edeline J.; Clinical impact of 99mTc-MAA SPECT\/CT-based dosimetry in the radioembolization of liver malignancies with 90Y-loaded microspheres. Eur J Nucl Med Mol Imaging  2016,43(3),559-575","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1007\/s00259-021-05600-z","volume":"49","author":"Weber M.","year":"2022","unstructured":"Weber M.; Lam M.; Chiesa C.; Konijnenberg M.; Cremonesi M.; Flamen P.; Gnesin S.; Bodei L.; Kracmerova T.; Luster M.; Garin E.; Herrmann K.; EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds. Eur J Nucl Med Mol Imaging  2022,49(5),1682-1699","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1097\/MNM.0000000000001089","volume":"40","author":"Elsayed M.","year":"2019","unstructured":"Elsayed M.; Martin J.G.; Dabrowiecki A.; Goldman D.T.; Faraj R.; McMahon J.T.; Kokabi N.; Duszak R.; Newsome J.; Bercu Z.L.; Tc-99m-MAA lung shunt fraction before Y-90 radioembolization is low among patients with non-hepatocellular carcinoma malignancies. Nucl Med Commun  2019,40(11),1154-1157","journal-title":"Nucl Med Commun"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/j.jvir.2016.06.004","volume":"27","author":"Kallini J.R.","year":"2016","unstructured":"Kallini J.R.; Gabr A.; Kulik L.; Salem R.; Lewandowski R.J.; The utility of unilobar technetium-99m macroaggregated albumin to predict pulmonary toxicity in bilobar hepatocellular carcinoma prior to yttrium-90 radioembolization. J Vasc Interv Radiol  2016,27(9),1453-1456","journal-title":"J Vasc Interv Radiol"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1007\/s00259-020-05163-5","volume":"48","author":"Levillain H.","year":"2021","unstructured":"Levillain H.; Bagni O.; Deroose CH.; Dieudonne A.; Gnesin S.; Grosser OS.; Kappadath C.; Kennedy A.; Kokabi N.; Liu DM.; Madoff DC.; Mahvash A.; Cuesta AM de la.; David CE Ng.; Paprottka PM.; Pettinato C.; Fraile MR.; Salem R.; Sangro B.; Strigari L.; Sze DY.; Wit ; van der veen BJ.; Flamen P.; International recommendations for personalised selective internal radiation therapy of primary and metastatic liver diseases with yttrium-90 resin microspheres. Eur J Nucl Med Mol Imaging  2021,48,1570-1584","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"3929","DOI":"10.1002\/mp.13575","volume":"46","author":"Lopez B.","year":"2019","unstructured":"Lopez B.; Mahvash A.; Lam M.G.E.H.; Kappadath S.C.; Calculation of lung mean dose and quantification of error for 90 Ymicrosphere radioembolization using 99m Tc-MAA SPECT\/CT and diagnostic chest CT. Med Phys  2019,46(9),3929-3940","journal-title":"Med Phys"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ejmp.2019.09.236","volume":"68","author":"Kim S.P.","year":"2019","unstructured":"Kim S.P.; Cohalan C.; Kopek N.; Enger S.A.; A guide to 90Y radioembolization and its dosimetry. Phys Med  2019,68,132-145","journal-title":"Phys Med"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.2967\/jnumed.112.105361","volume":"53","author":"Uliel L.","year":"2012","unstructured":"Uliel L.; Royal H.D.; Darcy M.D.; Zuckerman D.A.; Sharma A.; Saad N.E.; From the angio suite to the \u03b3-camera: Vascular mapping and 99mTc-MAA hepatic perfusion imaging before liver radioembolization--a comprehensive pictorial review. J Nucl Med  2012,53(11),1736-1747","journal-title":"J Nucl Med"},{"key":"ref=10","first-page":"1","volume":"4","author":"Kao Y.H.","year":"2014","unstructured":"Kao Y.H.; Magsombol B.M.; Toh Y.; Tay K.H.; Chow P.; Goh A.S.W.; David C.E.; Ng. Personalized predictive lung dosimetry by technetium- 99m macroaggregated albumin SPECT\/BT for yttrium -90 radioembolization. EJNMMI Pic  2014,4,1-12","journal-title":"EJNMMI Pic"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.ijrobp.2012.06.051","volume":"85","author":"Yu N.","year":"2013","unstructured":"Yu N.; Srinivas S.M.; DiFilippo F.P.; Shrikanthan S.; Levitin A.; McLennan G.; Spain J.; Xia P.; Wilkinson A.; Lung dose calculation with SPECT\/CT for 90Yittrium radioembolization of liver cancer. Int J Radiat Oncol Biol Phys  2013,85(3),834-839","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.2967\/jnumed.117.205203","volume":"59","author":"Dittmann H.","year":"2018","unstructured":"Dittmann H.; Kopp D.; Kupferschlaeger J.; Feil D.; Groezinger G.; Syha R.; Weissinger M.; la Foug\u00e8re C.; A prospective study of quantitative SPECT\/CT for evaluation of lung shunt fraction before SIRT of liver tumors. J Nucl Med  2018,59(9),1366-1372","journal-title":"J Nucl Med"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13550-018-0402-8","volume":"8","author":"Allred J.D.","year":"2018","unstructured":"Allred J.D.; Niedbala J.; Mikell J.K.; Owen D.; Frey K.A.; Dewaraja Y.K.; The value of 99mTc-MAA SPECT\/CT for lung shunt estimation in 90Y radioembolization: A phantom and patient study. EJNMMI Res  2018,8(1),50","journal-title":"EJNMMI Res"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"4824","DOI":"10.1118\/1.3608909","volume":"38","author":"Dezarn W.A.","year":"2011","unstructured":"Dezarn W.A.; Cessna J.T.; DeWerd L.A.; Feng W.; Gates V.L.; Halama J.; Kennedy A.S.; Nag S.; Sarfaraz M.; Sehgal V.; Selwyn R.; Stabin M.G.; Thomadsen B.R.; Williams L.E.; Salem R.; Recommendations of the American Association of Physicists in Medicine on dosimetry, imaging, and quality assurance procedures for 90 Y microsphere brachytherapy in the treatment of hepatic malignancies. Med Phys  2011,38(8),4824-4845","journal-title":"Med Phys"},{"key":"ref=15","first-page":"490","author":"Chiristopher A.","year":"2011","unstructured":"Chiristopher A.;  Pediatric Critical Care  2011,490","journal-title":"Pediatric Critical Care"},{"key":"ref=16","first-page":"193","author":"Netter F.H.","year":"2014","unstructured":"Netter F.H.;  Atlas of human anatomy PA  2014,193","journal-title":"Atlas of human anatomy PA"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s13139-015-0366-9","volume":"50","author":"Rhee S.","year":"2016","unstructured":"Rhee S.; Kim S.; Cho J.; Park J.; Eo J.S.; Park S.; Lee E.; Kim Y.H.; Choe J.G.; Semi-quantitative analysis of post-transarterial radioembolization 90y microsphere positron emission tomography combined with computed tomography (PET\/CT) images in advanced liver malignancy: Comparison with 99mTc macroaggregated albumin (MAA) single photon emission computed tomography (SPECT). Nucl Med Mol Imaging  2016,50(1),63-69","journal-title":"Nucl Med Mol Imaging"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.jvir.2020.12.023","volume":"32","author":"Villalobos A.","year":"2021","unstructured":"Villalobos A.; Cheng B.; Wagstaff W.; Sethi I.; Tumor - to -normal ratio relationship between planning Technetium-99 macroaggregated albumin and posttherapy Yttrium-90 Bremsstrahlung SPECT\/CT. J Vasc Interv Radiol  2021,32(5),752-760","journal-title":"J Vasc Interv Radiol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1080\/21681163.2018.1542348","volume":"7","author":"Demino L.","year":"2019","unstructured":"Demino L.; Ferreira P.; Oliveira F.P.M.; Costa D.C.; Comparison of the 90Y-labelled glass microspheres liver radioembolisation dosimetry with the estimated dosimetry obtained from pre-treatment 99mTc-MAA SPECT images reconstructed with and without attenuation correction. Comput Methods Biomech Biomed Eng Imaging Vis  2019,7(5-6),651-659","journal-title":"Comput Methods Biomech Biomed Eng Imaging Vis"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"4744","DOI":"10.1002\/mp.13168","volume":"45","author":"Kunnen B.","year":"2018","unstructured":"Kunnen B.; van der Velden S.; Bastiaannet R.; Lam M.G.E.H.; Viergever M.A.; de Jong H.W.A.M.; Radioembolization lung shunt estimation based on a 90 Y pretreatment procedure: A phantom study. Med Phys  2018,45(10),4744-4753","journal-title":"Med Phys"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1479-5876-5-15","volume":"5","author":"Gulec S.A.","year":"2007","unstructured":"Gulec S.A.; Mesoloras G.; Dezarn W.A.; McNeillie P.; Kennedy A.S.; Safety and efficacy of Y-90 microsphere treatment in patients with primary and metastatic liver cancer: The tumor selectivity of the treatment as a function of tumor to liver flow ratio. J Transl Med  2007,5(1),15","journal-title":"J Transl Med"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.1038\/s41598-021-82887-w","volume":"11","author":"Son M.H.","year":"2021","unstructured":"Son M.H.; Ha L.N.; Bang M.H.; Bae S.; Giang D.T.; Thinh N.T.; Paeng J.C.; Diagnostic and prognostic value of 99mTc-MAA SPECT\/CT for treatment planning of 90Y-resin microsphere radioembolization for hepatocellular carcinoma: comparison with planar image. Sci Rep  2021,11(1),3207","journal-title":"Sci Rep"}],"container-title":["Current Radiopharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0118744710284130240108053733","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/226374\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0118744710284130240108053733","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T14:53:08Z","timestamp":1722869588000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/226374\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0118744710284130240108053733","relation":{},"ISSN":["1874-4710"],"issn-type":[{"value":"1874-4710","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2023-09-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-10","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-26","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}